Employees engaged in the manufacture and processing of a drug product lack the training and experience required to perform their assigned functions.
See every finding in this document View official sourceBy Category
US FDA Training and personnel findings
by this agency in this category 399 findings drawn from 371 published documents. The most recent cases are below; the full set is in search.
See all US FDA Training and personnel findingsCompanies with the most findings
Recent findings
There is an inadequate number of personnel to manufacture and test APIs adequately.
See every finding in this document View official sourcePersonnel were observed moving quickly in a critical area or in an area immediately adjacent to a critical area likely causing disruption of unidirectional airflow.
See every finding in this document View official sourceProduction personnel were not practicing good sanitation and health habits.
See every finding in this document View official sourceEmployees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.
See every finding in this document View official sourceEmployees engaged in the manufacture, processing, packing and holding of a drug product lack the training required to perform their assigned functions.
See every finding in this document View official sourceOther agencies
These findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Counts are measured from public data as of 2026-09-04, and findings are extracted automatically from the regulator's published documents. “View official source” on each case links directly to that document.
